Sera Prognostics (SERA) Competitors

SBC Medical Group (NASDAQ:SBC) and Sera Prognostics (NASDAQ:SERA) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability, media sentiment and analyst recommendations.

Is SBC or SERA more profitable?

SBC Medical Group has a net margin of 17.71% compared to Sera Prognostics' net margin of -30,306.48%. SBC Medical Group's return on equity of 20.76% beat Sera Prognostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SBC Medical Group	17.71%	20.76%	15.56%
Sera Prognostics	-30,306.48%	-45.86%	-34.31%

Which has more risk and volatility, SBC or SERA?

SBC Medical Group has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Comparatively, Sera Prognostics has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500.

Do analysts recommend SBC or SERA?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Sera Prognostics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Does the media prefer SBC or SERA?

In the previous week, Sera Prognostics had 2 more articles in the media than SBC Medical Group. MarketBeat recorded 4 mentions for Sera Prognostics and 2 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 0.45 beat Sera Prognostics' score of 0.00 indicating that SBC Medical Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SBC Medical Group	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Sera Prognostics	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do institutionals and insiders have more ownership in SBC or SERA?

60.8% of SBC Medical Group shares are owned by institutional investors. Comparatively, 54.6% of Sera Prognostics shares are owned by institutional investors. 89.5% of SBC Medical Group shares are owned by company insiders. Comparatively, 13.5% of Sera Prognostics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Which has preferable valuation and earnings, SBC or SERA?

SBC Medical Group has higher revenue and earnings than Sera Prognostics. Sera Prognostics is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SBC Medical Group	$205.42M	2.11	$46.61M	$0.32	13.03
Sera Prognostics	$108K	1,116.24	-$32.90M	-$0.85	-3.76

Summary

SBC Medical Group beats Sera Prognostics on 11 of the 13 factors compared between the two stocks.